What to Do About It
The first step is a blood test. Serum B12, serum folate, and homocysteine together give a much clearer picture than any single marker alone. Homocysteine rises when either B12 or folate is low, and it can be a more sensitive early warning sign than the vitamins themselves. Methylmalonic acid, or MMA, is another marker that specifically indicates B12 status at the cellular level.
Anyone on GLP-1 treatment should ask their prescriber about baseline testing before starting and follow-up testing at regular intervals. The American Association of Clinical Endocrinologists recommends monitoring nutrient levels in patients undergoing medical weight loss, particularly those with restricted diets or a history of bariatric surgery.
If levels are low, supplementation is the standard approach. B12 supplements bypass the need for stomach acid and intestinal absorption because they are absorbed directly through the mucosa. Folate supplementation uses the synthetic form, folic acid, which is more bioavailable than food folate and does not depend on the same metabolic pathways.
Beyond supplements, adding functional foods that are dense in these nutrients can help. Salmon, eggs, and dairy provide B12. Lentils, asparagus, spinach, and avocado are strong sources of folate. When appetite is low, concentrating these nutrients into smaller portions matters more than eating larger volumes of lower-nutrient foods.
Tracking what you eat and how you feel over time makes it easier to spot patterns before they become problems. PeptPro has a meal scanner that helps you track micronutrient intake and organizes everything into a history you can bring to your appointment.
People who log their meals and symptoms consistently tend to catch deficiencies earlier. When fatigue shows up on a log alongside a sudden drop in protein-rich foods, that pattern becomes visible in a way that casual observation misses. Linking meals to energy levels and mood over weeks gives both patients and doctors a data set to work from rather than relying on memory.
Regular testing, ideally every three to six months during the first year of GLP-1 treatment, catches issues before they progress. Anyone with higher risk factors, such as plant-based eating or a history of malabsorption, may need more frequent monitoring.